Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does PIRTOBRUTINIB Cause Monocyte count increased? 8 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Monocyte count increased have been filed in association with PIRTOBRUTINIB (JAYPIRCA). This represents 1.8% of all adverse event reports for PIRTOBRUTINIB.

8
Reports of Monocyte count increased with PIRTOBRUTINIB
1.8%
of all PIRTOBRUTINIB reports
8
Deaths
8
Hospitalizations

How Dangerous Is Monocyte count increased From PIRTOBRUTINIB?

Of the 8 reports, 8 (100.0%) resulted in death, 8 (100.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.

Is Monocyte count increased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for PIRTOBRUTINIB. However, 8 reports have been filed with the FAERS database.

What Other Side Effects Does PIRTOBRUTINIB Cause?

Death (65) Malignant neoplasm progression (43) Disease progression (41) Pneumonia (41) Anaemia (27) Chronic lymphocytic leukaemia (25) Pancytopenia (22) Off label use (21) Drug ineffective (20) White blood cell count increased (19)

What Other Drugs Cause Monocyte count increased?

CLOZAPINE (582) RITUXIMAB (327) ADALIMUMAB (208) ETANERCEPT (199) METHOTREXATE (176) TOCILIZUMAB (168) PREDNISONE (138) HYDROXYCHLOROQUINE (133) SULFASALAZINE (132) INFLIXIMAB (129)

Which PIRTOBRUTINIB Alternatives Have Lower Monocyte count increased Risk?

PIRTOBRUTINIB vs PIT VIPER IMMUNE GLOBULIN ANTIVENIN PIRTOBRUTINIB vs PITAVASTATIN PIRTOBRUTINIB vs PITOLISANT PIRTOBRUTINIB vs PIXANTRONE PIRTOBRUTINIB vs PIZOTYLINE

Related Pages

PIRTOBRUTINIB Full Profile All Monocyte count increased Reports All Drugs Causing Monocyte count increased PIRTOBRUTINIB Demographics